{"id":"NCT03032380","sponsor":"Shionogi","briefTitle":"Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-24","primaryCompletion":"2019-02-26","completion":"2019-04-01","firstPosted":"2017-01-26","resultsPosted":"2020-11-13","lastUpdate":"2020-11-13"},"enrollment":300,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Healthcare-associated Pneumonia (HCAP)","Hospital Acquired Pneumonia (HAP)","Ventilator Associated Pneumonia (VAP)"],"interventions":[{"type":"DRUG","name":"Cefiderocol","otherNames":["S-649266"]},{"type":"DRUG","name":"Meropenem","otherNames":["Merrem®"]},{"type":"DRUG","name":"Linezolid","otherNames":["Zyvox®"]}],"arms":[{"label":"Cefiderocol","type":"EXPERIMENTAL"},{"label":"Meropenem","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this study is to compare all-cause mortality at Day 14 in participants receiving cefiderocol with participants receiving the comparator, meropenem, in adults with hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or healthcare-associated bacterial pneumonia (HCABP) caused by Gram-negative pathogens.","primaryOutcome":{"measure":"All-cause Mortality Rate at Day 14","timeFrame":"From first dose of study drug to Day 14","effectByArm":[{"arm":"Cefiderocol","deltaMin":12.4,"sd":null},{"arm":"Meropenem","deltaMin":11.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0020"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":2},"locations":{"siteCount":119,"countries":["United States","Belgium","Canada","Czechia","Estonia","France","Georgia","Germany","Hungary","Israel","Japan","Latvia","Philippines","Puerto Rico","Russia","Serbia","Spain","Taiwan","Ukraine"]},"refs":{"pmids":["35076335","35025025","34792787","33058798"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":148},"commonTop":["Hypokalaemia","Urinary tract infection","Diarrhoea","Anaemia","Aspartate aminotransferase increased"]}}